Cedilla Therapeutics (Series B)
Funding Details
Awarder
Inbox
Date Award
October 25, 2021
Vertical
Precision Oncology
Funding Amount
$82,600,000
Company Info
Market
Cancer Treatment
Location
Cambridge, MA, USA
Coinvestors
Janus Henderson Investors, Logos Capital, RA Capital Management, Third Rock Ventures, Woodline Partners
Company Description

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.